Clinical Trials
3 trialsNCT04887194 2024-05-08
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Mirati Therapeutics Inc.
Phase 1 Completed
NCT02908750 2022-11-14
Study to Assess the Effect of Osimertinib (TAGRISSOâ„¢ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed
NCT03976973 2022-03-15
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei
Mucpharm Pty Ltd
Phase 2 Unknown